Diagnosis of primary hyperaldosteronism;Diagnostik des primären hyperaldosteronismus

Medizinische Klinik

Volumn 102, Issue 1, 2007, Pages 16-22

  Diederich, Sven ^a,c   Bidlingmaier, Martin ^b   Quinkler, Marcus ^a   Reincke, Martin ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Endokrinologikum Berlin Am Gendarmenmarkt   (Germany)

Author keywords

Aldosterone renin ratio; Confirmatory tests; Differential diagnosis; Primary hyperaldosteronism; Screening

Indexed keywords

ALDOSTERONE; CLONIDINE; DOXAZOSIN; DROSPIRENONE; EPLERENONE; GESTAGEN; MINERALOCORTICOID ANTAGONIST; RENIN; SPIRONOLACTONE;

ADENOMA; ADRENAL CORTEX DISEASE; ADRENAL INCIDENTALOMA; ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HIGH SODIUM INTAKE; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; REVIEW; SCREENING TEST; URINALYSIS; VEIN CATHETERIZATION;

ADENOMA; ADRENAL GLAND NEOPLASMS; ALDOSTERONE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; MASS SCREENING; PREDICTIVE VALUE OF TESTS; RENIN;

EID: 33846456586     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-007-1002-y     Document Type: Review

References (27)

1. Gordon RD, Laragh JH, Funder JW. Low renin hypertensive states: perspectives, unsolved problems, future research. Trends Endocrinol Metab 2005;16:108-13.
2. Bähr V, Oelkers W, Diederich S. Monogenetische Hypertonien. Med Klin 2003;98:208-17.
3. Reincke M, Seiler L, Rump LC. Normokaliämischer primärer Hyperaldosteronismus. Dtsch Ärztebl 2003;100:A184-90.
4. Quinkler M, Lepenies J, Diederich S. Primary hyperaldosteronism. Exp Clin Endocrinol Diabetes 2002;110:263-71.
5. Mulatero P, Dluhy RG, Giacchetti G, et al. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab 2005;16:114-9.
6. Mosso L, Carvajal C, Gonzales A, et al. Primary aldosteronism and hypertensive disease. Hypertension 2003;42:161-5.
7. Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 2002;89:1587-93.
8. Quinkler M, Reincke M. Modern pharmacological aspects of hyperaldosteronism therapy. Internist (Berl) 2006;47:953-9.
9. Hartman D, Sagnella GA, Chesters CA, et al. Direct renin assay and plasma renin activity assay compared. Clin Chem 2004;50:2159-61.
10. Trenkel S, Seifarth C, Schobel H, et al. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. Exp Clin Endocrinol Diabetes 2002;110:80-5.
11. Ferrari P, Shaw SG, Nicod J, et al. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism. J Hypertens 2004;22:377-81.
12. Unger N, Lopez Schmidt I, Pitt C, et al. Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass. Eur J Endocrinol 2004;150:517-23.
13. Olivieri O, Ciacciarelli A, Signorelli D, et al. Aldosterone to renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab 2004;89:4221-6.
14. Perschel FH, Schemer R, Seiler L, et al. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem 2004;50:1650-5.
15. De Bruin RA, Bouhuizen A, Diederich S, et al. Validation of a new rapid renin assay. Clin Chem 2004;50:2111-6.
16. Mulatero P, Rabbio F, Milan A, et al. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002;40:897-902.
17. Seifarth C, Trenkel S, Schobel H, et al. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol (Oxf) 2002;57:457-65.
18. Lamarre-Cliche M, de Champlain J, Lacourciere Y, et al. Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives. Am J Hypertens 2005;18:56-64.
19. Schirpenbach C, Seiler L, Maser-Gluth C, et al. Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clin Chem 2006;52:1749-55.
20. Giacchetti G, Ronconi V, Lucarelli G, et al. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens 2006;24:737-45.
21. Mulatero P, Milan A, Fallo F, et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab 2006;91:2618-23.
22. Schirpenbach C, Seiler L, Maser-Gluth C, et al. Confirmatory testing in normokalaemic primary aldosteronism: the value of saline infusion test and urinary aldosterone metabolites. Eur J Endocrinol 2006;154:865-73.
23. Abdelhamid S, Blomer R, Hommel G, et al. Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study. Am J Hypertens 2003;16:522-30.
24. Young WF. Minireview: Primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinology 2003;144:2208-13.
25. Magill SB, Raff H, Shaker J, et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001;86:1066-71.
26. Philipps JL, Walther MM, Pezzulo JC, et al. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 2000;85:4526-33.
27. Espiner EA, Ross DG, Yandle TG, et al. Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing and adrenal vein sampling. J Clin Endocrinol Metab 2003;88:3637-44.